Outcomes of critically ill coronavirus disease 2019 patients requiring kidney replacement therapy: A retrospective

Josephine Braunsteiner1, Dominik Jarczak1, Christian Schmidt-Lauber2

  • 1Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Frontiers in Medicine
|November 7, 2022
PubMed

Insights

Nearly half of critically ill COVID-19 patients require kidney replacement therapy (KRT). This KRT initiation is linked to significantly higher intensive care unit (ICU) mortality rates.

Area of Science:

  • Nephrology
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) is a significant global health crisis with high hospitalization rates.
  • Acute kidney injury (AKI) is a common complication in COVID-19 patients, correlating with disease severity and adverse outcomes.
  • Understanding the need for kidney replacement therapy (KRT) and its impact on outcomes in critically ill COVID-19 patients is crucial.

Purpose of the Study:

  • To determine the incidence of kidney replacement therapy (KRT) among critically ill patients with COVID-19.
  • To investigate the factors associated with the initiation of KRT in this patient population.
  • To evaluate the implication of KRT on mortality in critically ill COVID-19 patients.

Main Methods:

  • Retrospective analysis of COVID-19 patients admitted to the Intensive Care Medicine department.
  • Data collection included demographics, clinical parameters, organ support, ICU stay length, mortality, and severity scores.
  • Statistical analysis, including logistic and Cox regression, was used to identify factors associated with KRT and mortality.

Main Results:

  • Out of 300 critically ill COVID-19 patients, 46% required KRT.
  • Factors independently associated with KRT initiation included septic shock, higher SAPS II scores, and vasopressor therapy.
  • Mortality in the ICU was significantly higher for patients who received KRT (61%) compared to those who did not (18%).

Conclusions:

  • Critically ill COVID-19 patients face a high risk of AKI, with approximately half requiring KRT.
  • KRT initiation in this cohort is independently associated with increased ICU mortality.
  • Early identification and management of AKI risk factors in COVID-19 patients are essential.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
59
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
53
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
67
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
40
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
76